Gary Hunter
A5050811879- Acute Ischemic Stroke Management
- Stroke Rehabilitation and Recovery
- Epilepsy research and treatment
- Cerebrovascular and Carotid Artery Diseases
- Venous Thromboembolism Diagnosis and Management
- Traumatic Brain Injury and Neurovascular Disturbances
- Intracerebral and Subarachnoid Hemorrhage Research
- Pharmacological Effects and Toxicity Studies
- EEG and Brain-Computer Interfaces
- Neuroscience and Neuropharmacology Research
- Cerebral Venous Sinus Thrombosis
- Health Systems, Economic Evaluations, Quality of Life
- Neonatal and fetal brain pathology
- Peripheral Neuropathies and Disorders
- Peripheral Artery Disease Management
- Infectious Encephalopathies and Encephalitis
- Cardiac Arrest and Resuscitation
- Hemoglobinopathies and Related Disorders
- Autoimmune Neurological Disorders and Treatments
- Cardiac electrophysiology and arrhythmias
- Malaria Research and Control
- Telemedicine and Telehealth Implementation
- Musculoskeletal pain and rehabilitation
- Metabolism and Genetic Disorders
- Mosquito-borne diseases and control
University of Saskatchewan
2016-2025
United Nations Economic and Social Commission for Asia and the Pacific
2021-2024
Arcadia
2024
Health and Education Research Management and Epidemiologic Services (United States)
2023
Royal University Hospital
2015-2023
Saskatchewan Health Authority
2020-2023
British Columbia Children's Hospital
2023
University of Manitoba
2023
Lakeridge Health
2023
Deleted Institution
2023
Abstract OBJECTIVE: To present an in-depth analysis of clinical predictors outcome including age, sex, etiology pain, type electrodes used, duration treatment, development tolerance, employment status, activities daily living, psychological and quality life. Suggestions for treatment low back pain with a predominant axial component are addressed. We analyzed the complications proposed remedial measures to improve effectiveness this modality. METHODS: Study group consists 410 patients (252...
It is unknown whether intravenous thrombolysis using tenecteplase noninferior or preferable compared with alteplase for patients acute ischemic stroke.
An abstract is not available for this content so a preview has been provided. As you have access to content, full PDF via the 'Save PDF' action button.
Every year, approximately 62,000 people with stroke and transient ischemic attack are treated in Canadian hospitals. The 2016 update of the Stroke Best Practice Recommendations Telestroke guideline is a comprehensive summary current evidence-based consensus-based recommendations appropriate for use by all healthcare providers system planners who organize provide care to patients following across broad range settings. These focus on telemedicine technologies rapidly identify treat acute...
Object. The object of this study was to compare the cost-effectiveness intrathecal drug therapy (IDT) with that conventional pain (CPT) in patients suffering from chronic low back caused by failed syndrome. In study, authors tabulated actual costs, Canadian dollars, a consecutive series undergoing IDT within health care system and have compared them costs control group same environment. influence these treatments on quality life (QOL) also analyzed. Methods. report 67 syndrome, 23 whom...
To evaluate the diagnostic accuracy of ambulatory EEG (aEEG) at detecting interictal epileptiform discharges (IEDs)/seizures compared with routine (rEEG) and repetitive/second rEEG in patients a first single unprovoked seizure (FSUS). We also evaluated association between IED/seizures on aEEG recurrence within 1 year follow-up.
Understanding sex differences in stroke care is important reducing potential disparities. Our objective was to explore workflow efficiency, treatment efficacy, and safety the AcT trial (Alteplase Compared Tenecteplase).
Background and Objectives: Transportation to comprehensive stroke centers (CSCs) from primary (PSCs) is key achieving fast reperfusion in endovascular treatment (EVT)-eligible patients. We aimed evaluate outcomes workflow times of patients treated PSCs vs CSCs additional metrics for those transported EVT. Methods: performed a pre-specified analysis the Alteplase compared Tenecteplase (AcT) multicenter, randomized, controlled, trial with acute ischemic within 4.5 hours onset. baseline...
Introduction Fast delivery of intravenous thrombolysis (IVT) and transportation to a comprehensive stroke center (CSC) is paramount in primary centers (PSCs), achieve effective reperfusion. We investigated clinical outcomes workflow times patients treated with IVT at PSCs. Methodology This secondary analysis the AcT trial, multicenter, phase-3, randomized, controlled, noninferiority trial comparing tenecteplase alteplase acute ischemic within 4.5 hours onset. compared baseline...
BACKGROUND: Older age has been associated with overall poorer outcomes in acute ischemic stroke. We compared (1) various health-related domains among patients <80 years and ≥80 presenting stroke (2) whether differ between intravenous TNK (tenecteplase) versus alteplase. METHODS: Data are from included AcT (Alteplase Compared to Tenecteplase Patients With Acute Ischemic Stroke), a pragmatic, registry-linked, phase 3 randomized controlled trial comparing Outcomes functional disability (per...
Summary Purpose : To identify the prevalence of injuries in people with epilepsy (PWE) general population. Method We examined obtained through previously validated, door‐to‐door Canadian Community Health Survey (CHS) (n = 130,882). The 12‐month weighted serious enough to limit normal activities was calculated for and Among those reporting injuries, variables interest were compared PWE population using risk ratios (RR) their 95% confidence intervals (CI 95 ). Results not different (14.9%)...
Background: Carotid tandem lesions ((TL) ⩾70% stenosis or occlusion) account for 15–20% of acute stroke with large vessel occlusion. Aims: We investigated the safety and efficacy intravenous tenecteplase (0.25 mg/kg) versus alteplase (0.9 in patients carotid TL. Methods: This is a substudy compared trial. Patients extracranial internal artery (ICA) concomitant occlusion intracranial ICA, M1 M2 segments middle cerebral on baseline computed tomography angiography (CTA) were included. Primary...
The AcT (Alteplase Compared to Tenecteplase) randomized controlled trial showed that tenecteplase is noninferior alteplase in treating patients with acute ischemic stroke within 4.5 hours of symptom onset. effect time treatment on clinical outcomes well known; however, the nature this relationship yet be described tenecteplase. We assessed whether association thrombolysis differs by they receive intravenous versus alteplase. Patients included were from AcT, a pragmatic, registry-linked,...
Background Intravenous thrombolysis with alteplase is widely used in patients acute ischemic stroke presenting early after symptom onset. Recent phase II trials have suggested that intravenous tenecteplase may be safer and associated higher reperfusion rates as compared alteplase. This study investigates whether noninferior to for the treatment of stroke. Methods a pragmatic, registry‐linked, prospective, randomized (1:1) controlled, open‐label parallel group clinical trial (AcT [Alteplase...